Trial intelligence / Profile preview

Topical tranexamic acid for treatment of epistaxis

IRCT20221230056992N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in epistaxis, sponsored by Mashhad University of Medical Sciences. Started Dec 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

epistaxis

Beyond the preview

Go deeper on IRCT20221230056992N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221230056992N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call